261 related articles for article (PubMed ID: 6319296)
1. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines.
Takada K
Int J Cancer; 1984 Jan; 33(1):27-32. PubMed ID: 6319296
[TBL] [Abstract][Full Text] [Related]
2. Subpopulations of human lymphoblastoid cell lines. Correlation with the expression of surface receptors and content of Epstein-Barr virus genome.
Yount WJ; Utsinger PD; Hutt LM; Buchanan PD; Korn JH; Fuller CR; Logue M; Pagano JS
Scand J Immunol; 1976; 5(6-7):795-810. PubMed ID: 62390
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.
Yang L; Hakoda M; Iwabuchi K; Takeda T; Koike T; Kamatani N; Takada K
J Virol; 2004 Sep; 78(18):9918-23. PubMed ID: 15331725
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
Iwakiri D; Takada K
J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
[TBL] [Abstract][Full Text] [Related]
6. Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines.
Gordon J; Melamed MD; Ley SC; Hughes-Jones NC
Immunology; 1984 May; 52(1):79-85. PubMed ID: 6325331
[TBL] [Abstract][Full Text] [Related]
7. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
8. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells.
Kalchschmidt JS; Bashford-Rogers R; Paschos K; Gillman AC; Styles CT; Kellam P; Allday MJ
J Exp Med; 2016 May; 213(6):921-8. PubMed ID: 27217538
[TBL] [Abstract][Full Text] [Related]
10. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
11. Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.
Epstein AL; Henle W; Henle G; Hewetson JF; Kaplan HS
Proc Natl Acad Sci U S A; 1976 Jan; 73(1):228-32. PubMed ID: 174098
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
13. Classification and biological nature of established human hematopoietic cell lines.
Nilsson K; Pontén J
Int J Cancer; 1975 Feb; 15(2):321-41. PubMed ID: 165156
[TBL] [Abstract][Full Text] [Related]
14. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
15. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines.
Yefenof E; Klein G
Int J Cancer; 1977 Sep; 20(3):347-52. PubMed ID: 198382
[TBL] [Abstract][Full Text] [Related]
16. Chromosome translocations, surface immunoglobulins, and Epstein-Barr virus in Japanese Burkitt's lymphoma.
Sakurai M; Hayashi Y; Abe R; Nakazawa S
Cancer Genet Cytogenet; 1983 Mar; 8(3):275-6. PubMed ID: 6297707
[No Abstract] [Full Text] [Related]
17. The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors.
Patarroyo M; Klein E; Klein G
Cell Immunol; 1982 Feb; 67(1):152-9. PubMed ID: 6176334
[No Abstract] [Full Text] [Related]
18. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
19. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
20. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
